WE FUND RESEARCH INTO ANY TYPE OF CANCER, ANYWHERE IN THE WORLD
Leaving a gift in your Will is an easy way to make a difference in the fight against cancer.
Sign-up to get our free info pack and learn more about how you can support the best cancer research projects in the world.
Join us for Scotland’s biggest weekend of running! We have a limited number of FREE charity places.
Join the Team
Olaparib is the first of a new class of cancer drugs called PARP inhibitors. In December 2015, olaparib was approved for ovarian cancer treatment in the UK, and Worldwide Cancer Research played a part in its development.
Find out More